Toxic Multinodular Goiter

• CLINICAL_TRIALS research · 2026-02-10
  Clinical Trial Update: Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter [Phase 3]

  Phase 3 clinical trial evaluating preoperative Lugol's solution in Graves' disease and toxic multinodular goiter; the study is currently rec…

• CLINICAL_TRIALS withdrawal · 2025-10-02
  Clinical Trial Update: Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery

  A prospective observational trial investigating carotid intima-media thickness in patients undergoing thyroid surgery has been withdrawn.

• CLINICAL_TRIALS research · 2025-09-08
  Clinical Trial Update: Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

  A multicenter registry update for the PROTECT trial of pressure-enabled retrograde occlusive therapy with embolization aimed at controlling …

• FDA approval · 2024-06-26
  FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA approved a supplemental application for Propylthiouracil from Macleods Pharmaceuticals Limited (ANDA208867).

• FDA approval · 2019-01-18
  FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)

  The FDA approved a supplemental application for methimazole submitted by NorthStar RX LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-01-15
  FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)

  FDA approved a supplemental application for methimazole submitted by Strides Pharma Science Limited.

• FDA approval · 2007-04-18
  FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

  The FDA approved a supplemental application for HICON (sodium iodide I-131) submitted by Jubilant DraxImage Inc., dba Jubilant Radiopharma.